Topical Management of Pediatric Psoriasis: A Review of New Developments and Existing Therapies
出版年份 2023 全文链接
标题
Topical Management of Pediatric Psoriasis: A Review of New Developments and Existing Therapies
作者
关键词
-
出版物
PEDIATRIC DRUGS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-17
DOI
10.1007/s40272-023-00592-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study
- (2023) Megan N Landis et al. BRITISH JOURNAL OF DERMATOLOGY
- Tapinarof cream 1% once daily for the treatment of plaque psoriasis: Patient-reported outcomes from the PSOARING 3 trial
- (2023) Jerry Bagel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A critical review of halobetasol propionate foam (0.05%) as a treatment option for adolescent plaque psoriasis
- (2022) Mimi Chung et al. Expert Review of Clinical Immunology
- One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial
- (2022) Bruce Strober et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis
- (2022) Mark G. Lebwohl et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies
- (2022) Archie W. Thurston et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Tapinarof cream 1% once daily and benvitimod 1% twice daily are 2 distinct topical medications
- (2021) Linda Stein Gold et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- 27874 Correlation of itch response to roflumilast cream with disease severity and patient-reported outcomes in patients with chronic plaque psoriasis
- (2021) Linda Stein Gold et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics
- (2021) John E. Jett et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- New Topical Therapies for Psoriasis
- (2021) Ana Maria Lé et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis
- (2021) Mark G. Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of fixed‐dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam in adolescent patients (aged 12 to
- (2020) M. Seyger et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis
- (2020) Masutaka Furue INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures
- (2020) Craig A. Elmets et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treating Scalp Psoriasis With Fixed-dose Combination Calcipotriene/Betamethasone Dipropionate Cutaneous Foam: Review of Phase 2 Data
- (2020) Bibi Petersen et al. Journal of Drugs in Dermatology
- Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
- (2019) Masutaka Furue et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients
- (2019) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment of psoriasis with crisaborole
- (2018) Erica B. Lee et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Pediatric psoriasis: Evolving perspectives
- (2018) Lawrence F. Eichenfield et al. PEDIATRIC DERMATOLOGY
- Long-term safety results from a Phase 3 open-label study of a fixed combination halobetasol propionate 0.01% and tazarotene 0.045% (HP/TAZ) lotion in moderate-to-severe plaque psoriasis
- (2018) Mark G. Lebwohl et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Topical Crisaborole—A Potential Treatment for Recalcitrant Palmoplantar Psoriasis
- (2018) Allison B. Robbins et al. JAMA Dermatology
- Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans
- (2017) Susan H. Smith et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
- (2015) Kim Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis
- (2013) W.C. Ports et al. BRITISH JOURNAL OF DERMATOLOGY
- The Burden of Childhood Psoriasis
- (2011) MICHELLE E.A. De JAGER et al. PEDIATRIC DERMATOLOGY
- Urinary mutagenicity and genotoxic risk in children with psoriasis after therapeutic exposure to polycyclic aromatic hydrocarbons and ultraviolet radiation
- (2010) Lenka Borska et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Psychiatric Symptoms and Health-Related Quality of Life in Children and Adolescents with Psoriasis
- (2010) Ayhan Bilgic et al. PEDIATRIC DERMATOLOGY
- Results of Goeckerman Treatment for Psoriasis in Children: A 21-Year Retrospective Review
- (2010) Kimberly R. Kortuem et al. PEDIATRIC DERMATOLOGY
- Epidemiology and comorbidity of psoriasis in children
- (2009) M. Augustin et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of treatments for childhood psoriasis: A systematic literature review
- (2009) Michelle E.A. de Jager et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Genotoxic Hazard and Cellular Stress in Pediatric Patients Treated for Psoriasis with the Goeckerman Regimen
- (2009) Lenka Borska et al. PEDIATRIC DERMATOLOGY
- Clobetasol propionate emollient formulation foam in the treatment of corticosteroid-responsive dermatoses
- (2008) Jason E Frangos et al. EXPERT OPINION ON PHARMACOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started